跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 36,396 条关于
“HER2-targeted drugs”
全部
36,396
临床试验
18,413
药物
1,377
机构
261
资讯
16,345
去年
Lantern Pharma's LP-184 Receives FDA Fast Track Designation for Triple-Negative Breast Cancer
去年
INOVIQ's Exosome Therapy Shows Promise in Triple-Negative Breast Cancer
去年
Personalized Vaccine Shows Promise in Triple-Negative Breast Cancer
去年
AI Tools Show Promise in Improving HER2 Breast Cancer Classification and Treatment Eligibility
去年
ANGLE's Parsortix System Shows Promise in Real-Time HER2 Status Monitoring for Breast Cancer Patients
去年
HER2-Targeted Therapies Solidify Role in Early-Stage HER2-Positive Breast Cancer Treatment
去年
FDA Approves Zanidatamab (Ziihera) for HER2-Positive Biliary Tract Cancer
3个月前
HER2-LADDER: A Spatially Interpretable AI Framework Predicts Neoadjuvant Dual HER2-Targeted Therapy Response in Breast Cancer
2年前
Disitamab Vedotin Plus Pembrolizumab Shows Promise in HER2-Expressing Urothelial Cancer
9个月前
Next-Generation HER2-Targeted ADCs Show Promise in Breast Cancer Trials
第 1 页,共 1635 页
上一页
下一页